TY  - GEN
AU  - Ahmadieh,Hamid
AU  - Taei,Ramin
AU  - Riazi-Esfahani,Mohammad
AU  - Piri,Niloufar
AU  - Homayouni,Mansour
AU  - Daftarian,Narsis
AU  - Yaseri,Mehdi
TI  - Intravitreal bevacizumab versus combined intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration: six-month results of a randomized clinical trial
SN  - 1539-2864
PY  - 2012///0321
KW  - Aged
KW  - Aged, 80 and over
KW  - Angiogenesis Inhibitors
KW  - therapeutic use
KW  - Antibodies, Monoclonal, Humanized
KW  - Bevacizumab
KW  - Drug Therapy, Combination
KW  - Female
KW  - Fluorescein Angiography
KW  - Follow-Up Studies
KW  - Glucocorticoids
KW  - Humans
KW  - Intravitreal Injections
KW  - Male
KW  - Middle Aged
KW  - Prospective Studies
KW  - Retreatment
KW  - Tomography, Optical Coherence
KW  - Treatment Outcome
KW  - Triamcinolone Acetonide
KW  - Vascular Endothelial Growth Factor A
KW  - antagonists & inhibitors
KW  - Visual Acuity
KW  - physiology
KW  - Wet Macular Degeneration
KW  - diagnosis
N1  - Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1097/IAE.0b013e31820d58f2
ER  -